25 - 26 March 2021

8th Edition MarketsandMarkets Biomarker and Companion Diagnostics Virtual Conference ( Time Zone - CENTRAL EUROPEAN TIME (CET)

The 8th Edition Biomarker and Companion Diagnostics Virtual Conference scheduled to be held on 25 - 26 March 2021 would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. 

Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
 

WHAT TO EXPECT
Key Highlights
  • Biomarker Drug Discovery and Assay Development
  • Proteomics and Genomics based Biomarkers
  • Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
  • Commercialization of CDx
  • Multiplex Companion Diagnostics and Regulatory Guidelines
  • Design of clinical trials in CDx
  • Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases
Who Should Attend?

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Victoria Sanz-Moreno

Victoria Sanz-Moreno

Professor, Cancer Cell Biology
Cancer Research UK Barts Centre, UK

Victoria Sanz-Moreno

Professor, Cancer Cell Biology
Cancer Research UK Barts Centre, UK
Deyarina Gonzalez

Deyarina Gonzalez

Professor, Molecular Medicine
Swansea University Medical School, UK

Deyarina Gonzalez

Professor, Molecular Medicine
Swansea University Medical School, UK
 Karla Allebrandt

Karla Allebrandt

Digital Biomarkers Strategy Lead
Boehringer Ingelheim, Germany

Karla Allebrandt

Digital Biomarkers Strategy Lead
Boehringer Ingelheim, Germany
Colin Self

Colin Self

CEO
Precision Therapeutics

Colin Self

CEO
Precision Therapeutics
Francesc Mitjans,

Francesc Mitjans,

Chief Scientific Officer
Lykera Biomed, Spain

Francesc Mitjans,

Chief Scientific Officer
Lykera Biomed, Spain
Eike Staub

Eike Staub

Head, Oncology Bioinformatics
Merck Healthcare, Germany

Eike Staub

Head, Oncology Bioinformatics
Merck Healthcare, Germany
Markus Zettl

Markus Zettl

Director, Immuno-Oncology
Pieris Pharmaceuticals, Germany

Markus Zettl

Director, Immuno-Oncology
Pieris Pharmaceuticals, Germany
Bogdan Munteanu

Bogdan Munteanu

Lab Head, Global Imaging Mass Spectrometry Biomarker Discovery Platform (DMPK)
Sanofi, Germany

Bogdan Munteanu

Lab Head, Global Imaging Mass Spectrometry Biomarker Discovery Platform (DMPK)
Sanofi, Germany
SPONSORS
Platinium
example-image

Larvol

example-image

NeoGenomics

example-image

Agilent

example-image

QIAGEN

Gold
example-image

Owlstone Medical

Silver
example-image

Abcam

Meeting Partner
example-image

Burning Rock

PAST EVENT GALLERY